glutathione liver mitocondria disease Mitochondrial metabolic dysfunction and non-alcoholic fatty disease: new insights from pathogenic mechanisms to clinically targeted therapy | Journal of Translational Medicine Mitochondrial diseases: from molecular mechanisms
Mitochondrial diseases: from molecular mechanisms to therapeutic advances Signal Transduction and Targeted Therapy Mitochondrial Dysfunction in Metabolic Dysfunction Fatty Liver Disease (MAFLD) Controlling glutathione entry into mitochondria: potential roles for SLC25A39 in health and (treatment of) disease Signal Transduction and Targeted Therapy Emerging role of ferroptosis in metabolic dysfunction associated steatotic liver disease: revisiting hepatic lipid peroxidation eBioMedicine
Pay in 4 interest-free payments of $5.36 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9



